Jpmorgan Chase & CO Foghorn Therapeutics Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,966 shares of FHTX stock, worth $86,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,966
Previous 11,053 0.79%
Holding current value
$86,631
Previous $63,000 61.9%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$4.8 - $9.99 $417 - $869
-87 Reduced 0.79%
10,966 $102,000
Q2 2024

Aug 12, 2024
SELL
$5.05 - $8.0 $15,074 - $23,880
-2,985 Reduced 21.26%
11,053 $63,000
Q1 2024

May 10, 2024
BUY
$2.82 - $7.94 $2,430 - $6,844
862 Added 6.54%
14,038 $94,000
Q4 2023

Feb 12, 2024
SELL
$2.94 - $6.76 $23,052 - $53,005
-7,841 Reduced 37.31%
13,176 $84,000
Q3 2023

Nov 14, 2023
BUY
$5.0 - $9.87 $19,605 - $38,700
3,921 Added 22.94%
21,017 $105,000
Q2 2023

Aug 11, 2023
BUY
$5.37 - $8.84 $8,570 - $14,108
1,596 Added 10.3%
17,096 $120,000
Q1 2023

May 18, 2023
BUY
$4.66 - $8.99 $71,736 - $138,392
15,394 Added 14522.64%
15,500 $96,000
Q1 2023

May 11, 2023
SELL
$4.66 - $8.99 $52,513 - $101,308
-11,269 Reduced 99.07%
106 $0
Q4 2022

Feb 13, 2023
BUY
$5.44 - $9.46 $2,148 - $3,736
395 Added 3.6%
11,375 $73,000
Q3 2022

Nov 14, 2022
BUY
$7.52 - $18.01 $1,774 - $4,250
236 Added 2.2%
10,980 $94,000
Q2 2022

Aug 11, 2022
BUY
$8.48 - $16.84 $13,313 - $26,438
1,570 Added 17.11%
10,744 $146,000
Q1 2022

May 11, 2022
BUY
$8.87 - $22.1 $14,759 - $36,774
1,664 Added 22.16%
9,174 $140,000
Q4 2021

Feb 10, 2022
SELL
$10.79 - $22.87 $45,231 - $95,871
-4,192 Reduced 35.82%
7,510 $172,000
Q3 2021

Nov 12, 2021
BUY
$8.33 - $15.02 $97,477 - $175,764
11,702 New
11,702 $163,000

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $329M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email